TELETRADER News
8/4, 3:11 AM (Source: TeleTrader)
more TeleTrader news

Pfizer-1.53%

43.80
Chart for: Pfizer Inc

FDA to grant Pfizer jab full approval by September

The United States Food and Drug Administration is expected to grant the Pfizer/BioNTech coronavirus vaccine full approval by early September, the New York Times reported citing people familiar with the matter.

After receiving emergency approval for the jab in late 2020, Pfizer filed for full approval in May.

Last week, reports emerged that the FDA is planning to accelerate the approval process for the Pfizer vaccine.

Breaking the News / NP